BioLineRx Ltd.
BioLineRx Ltd. (BLRX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BLRX · as of Mar 31, 2025
Ownership Breakdown
12
Institutional Holders
▼ 21 vs Q4
$27,997
Total Inst. Value
▼ $403,586 vs Q4
4.35M
Shares Outstanding
freeFloat 99.83%
9,460
13F Shares Held
▼ 2.03M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BLRX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 3.0K | 7.60% | 7.60% | $8.88M | May 13, 2025 | NEW |
MORGAN STANLEY pharmaceutical preparations | 2.2K | 5.68% | 5.68% | $6.64M | May 15, 2025 | NEW |
BNP PARIBAS ARBITRAGE, SNC pharmaceutical preparations | 1.7K | 4.43% | 4.43% | $5.17M | May 14, 2025 | NEW |
RHUMBLINE ADVISERS pharmaceutical preparations | 1.5K | 3.87% | 3.87% | $4.52M | May 29, 2025 | NEW |
JPMORGAN CHASE & CO pharmaceutical preparations | 375 | 0.95% | 0.95% | $1.11M | May 12, 2025 | NEW |
NEMES RUSH GROUP LLC pharmaceutical preparations | 300 | 0.76% | 0.76% | $888,000 | May 7, 2025 | NEW |
NEWEDGE ADVISORS, LLC pharmaceutical preparations | 107 | 0.27% | 0.27% | $317,000 | May 15, 2025 | NEW |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 79 | 0.20% | 0.20% | $234,000 | May 14, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 71 | 0.18% | 0.18% | $210,000 | May 13, 2025 | NEW |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 2 | 0.01% | 0.01% | $6,000 | May 15, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares12
New Positions
first time holders0
Decreased
−0 shares31
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-19
12 new / 31 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BLRX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
BioLineRx Ltd. (BLRX) is primarily owned by institutional investors, who hold approximately 0.2% of total shares outstanding. Company insiders own approximately 0.17%, while retail and public investors account for the remaining 99.61%.
The largest institutional shareholder of BioLineRx Ltd. is WELLS FARGO & COMPANY/MN, holding approximately 3,000 shares — equal to 7.60% of outstanding shares — as of March 31, 2025.
A total of 12 institutional investors currently hold BLRX stock, with a combined institutional value of approximately $27,997 as of the most recent 13F filing period.
Frequently asked questions
BLRX ownershipBioLineRx Ltd. (BLRX) is primarily owned by institutional investors, who hold approximately 0.2% of shares. The largest shareholder is WELLS FARGO & COMPANY/MN with a 7.60% stake. Company insiders hold 0.17%. Data sourced from SEC Form 13F as of March 31, 2025.